SCHEMBL30984097

SCHEMBL30984097

N#CC1(Oc2ncnc3c2nc(-c2ccc(OCCN4CCNCC4)cc2Cl)n3Cc2ccccc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.40
▸ LTA4H P09960 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ PRKAB2 O43741 1/20 0.34
▸ PRKAG1 P54619 1/20 0.34
▸ PRKAA2 P54646 1/20 0.34
▸ PRKAA1 Q13131 1/20 0.34
▸ PRKAG3 Q9UGI9 1/20 0.34
▸ PRKAG2 Q9UGJ0 1/20 0.34
▸ PRKAB1 Q9Y478 1/20 0.34
▸ HRH4 Q9H3N8 4/20 0.34
▸ CNR1 P21554 2/20 0.33
▸ CNR2 P34972 2/20 0.33
▸ RET P07949 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983545 0.94 KDM4E (0.39) PDE2ALTA4HKDM4EALDH1A1HRH4
SCHEMBL30983516 0.93 PDE2A (0.40) PDE2ALTA4HKDM4EALDH1A1PRKAB2
SCHEMBL30983434 0.90 PDE2A (0.39) PDE2ALTA4HKDM4EALDH1A1PRKAB2
SCHEMBL30983795 0.89 PDE2A (0.42) PDE2ALTA4HKDM4EALDH1A1PRKAB2
SCHEMBL30984056 0.88 PDE2A (0.42) PDE2ALTA4HKDM4EALDH1A1HRH4
SCHEMBL30983609 0.88 PDE2A (0.42) PDE2ALTA4HKDM4EALDH1A1HRH4
SCHEMBL30984054 0.88 PDE2A (0.42) PDE2ALTA4HKDM4EALDH1A1HRH4
SCHEMBL30983785 0.85 CNR1 (0.41) CNR1CNR2RET
SCHEMBL30983420 0.85 HRH4 (0.41) PDE2ALTA4HALDH1A1PRKAB2PRKAG1
Hydrochloric Acid SCHEMBL30983886 0.84 LTA4H (0.45) PDE2ALTA4HKDM4EALDH1A1PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback